AUPH - Aurinia Pharmaceuticals Inc.
14.81
0.010 0.068%
Share volume: 649,292
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$14.80
0.01
0.00%
Summary score
65%
Profitability
65%
Dept financing
25%
Liquidity
75%
Performance
74%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-1.46%
Return on sales
-31.65%
Return on invested capital
0%
Total debt ratio
24.52%
Debt ratio change over timeo
0%
Current Ratio
7.45%
Quick Ratio
6.87%
Cash Position Ratio
1.45%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
4.6%
Return on sales
36.81%
Return on invested capital
0%
Total debt ratio
29.31%
Debt ratio change over timeo
0%
Current Ratio
5.54%
Quick Ratio
4.95%
Cash Position Ratio
0.87%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
4.42%
Return on sales
43.1%
Return on invested capital
0%
Total debt ratio
22.65%
Debt ratio change over time
0%
Current Ratio
5.25%
Quick Ratio
4.76%
Cash Position Ratio
0.86%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AUPH | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -1.46% | 4.74% | 3.19% | 1.73% |
| Return on sales | -31.65% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 24.52% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 0% | -20.57% | -85.61% | 17.33% |
| Dept financing | 7% | 21% | 16% | 50% |
| Current Ratio | 5.54% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 4.95% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.87% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 10% | 16% | 10% |
| Short-term ratios | AUPH | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 4.6% | 6.06% | 4.18% | 1.7% |
| Return on sales | 36.81% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 92% | 50% | 34% | 23% |
| Total debt ratio | 29.31% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 20% | 15% | 25% |
| Current Ratio | 5.54% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 4.95% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.87% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 17% | 22% | 10% |